Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Pharmacogenetics Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Cytochrome P-450 CYP2D6 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2014 2018

Research Output 2009 2017

1 Citations

Clinical and genome-wide analysis of cisplatin-induced peripheral neuropathy in survivors of adult-onset cancer

Dolan, M. E., Charif, O. E., Wheeler, H. E., Gamazon, E. R., Ardeshir-Rouhani-fard, S., Monahan, P., Feldman, D. R., Hamilton, R. J., Vaughn, D. J., Beard, C. J., Fung, C., Kim, J., Fossa, S. D., Hertz, D. L., Mushiroda, T., Kubo, M., Einhorn, L. H., Cox, N. J. & Travis, L. B. Oct 1 2017 In : Clinical Cancer Research. 23, 19, p. 5757-5768 12 p.

Research output: Research - peer-reviewArticle

Peripheral Nervous System Diseases
Cisplatin
Genome
Neoplasms
Testicular Neoplasms
1 Citations

Comprehensive assessment of cytochromes P450 and transporter genetics with endoxifen concentration during tamoxifen treatment

Marcath, L. A., Deal, A. M., Van Wieren, E., Danko, W., Walko, C. M., Ibrahim, J. G., Weck, K. E., Jones, D. R., Desta, Z., McLeod, H. L., Carey, L. A., Irvin, W. J. & Hertz, D. L. 2017 In : Pharmacogenetics and Genomics. 27, 11, p. 402-409 8 p.

Research output: Research - peer-reviewArticle

Tamoxifen
Cytochrome P-450 Enzyme System
Therapeutics
4-hydroxy-N-desmethyltamoxifen
Cytochrome P-450 CYP2D6

CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study

Hertz, D. L., Kidwell, K. M., Hilsenbeck, S. G., Oesterreich, S., Osborne, C. K., Philips, S., Chenault, C., Hartmaier, R. J., Skaar, T. C., Sikora, M. J. & Rae, J. M. Nov 1 2017 In : Breast Cancer Research and Treatment. 166, 1, p. 277-287 11 p.

Research output: Research - peer-reviewArticle

Cytochrome P-450 CYP2D6
Tamoxifen
Genotype
Breast Neoplasms
Survival
4 Citations

Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity

Ahern, T. P., Hertz, D. L., Damkier, P., Ejlertsen, B., Hamilton-Dutoit, S. J., Rae, J. M., Regan, M. M., Thompson, A. M., Lash, T. L. & Cronin-Fenton, D. P. Jan 15 2017 In : American Journal of Epidemiology. 185, 2, p. 75-85 11 p.

Research output: Research - peer-reviewReview article

Loss of Heterozygosity
Tamoxifen
Cytochrome P-450 Enzyme System
Genotype
Breast Neoplasms
4 Citations

Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer

Robarge, J. D., Desta, Z., Nguyen, A. T., Li, L., Hertz, D., Rae, J. M., Hayes, D. F., Storniolo, A. M., Stearns, V., Flockhart, D. A., Skaar, T. C. & Henry, N. L. Feb 1 2017 In : Breast Cancer Research and Treatment. 161, 3, p. 453-461 9 p.

Research output: Research - peer-reviewArticle

exemestane
letrozole
Estrogens
Breast Neoplasms
Therapeutics